Dr Gisela Robles Aguilar
Contact information
Research groups
Gisela Robles Aguilar
Global Burden of Disease Researcher
Gisela joined GRAM as a Global Burden of Disease Researcher in 2018, and she supports efforts to estimate the burden of antimicrobial resistance worldwide and inform public health decision-making at the local and international levels. In the last three years, Gisela has collaborated with the Lancet Noncommunicable Diseases and Injuries (NCDIs) Poverty Commission by profiling risk factors to NCDIs across the poorest populations in the World, applying methodologies utilised by the Institute of Health Metrics (IHME) in its ongoing Global Burden of Disease (GBD) study. Gisela has also served as a Data Analyst at Oxford’s Clinical Trials Service Unit and Research Officer at the Oxford Poverty and Human Development Initiative (OPHI).
Gisela received her DPhil in Social Policy from Oxford in 2014, with a focus on modelling participation in conditional cash transfers.
Recent publications
-
The burden of antimicrobial resistance in the Americas in 2019: a cross-country systematic analysis
Aguilar GR. et al, (2023), The Lancet Regional Health - Americas, 100561 - 100561
-
Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019
Ikuta KS. et al, (2022), The Lancet, 400, 2221 - 2248
-
The burden of bacterial antimicrobial resistance in the WHO European region in 2019: a cross-country systematic analysis
Mestrovic T. et al, (2022), The Lancet Public Health, 7, e897 - e913
-
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis
Murray CJL. et al, (2022), The Lancet, 399, 629 - 655
-
Burden of disease among the world's poorest billion people: An expert-informed secondary analysis of Global Burden of Disease estimates.
Coates MM. et al, (2021), PloS one, 16